According to GuruFocus Insider Data, these are the largest CFO buys during the past week. The overall trend of CFOs is illustrated in the chart below:
ZBB Energy Corporation (ZBB): CFO William C. Hogoboom Bought 28,947 Shares
CFO of ZBB Energy Corporation (ZBB) William C. Hogoboom bought 28,947 shares on 06/14/2012 at an average price of $0.38. ZBB Energy Corporation develops and manufactures distributed energy storage solutions based on the Company's proprietary zinc-bromine rechargeable electrical energy storage technology. ZBB Energy Corporation has a market cap of $16.2 million; its shares were traded at around $0.35 with and P/S ratio of 9.
ZBB Energy Corporation reported revenues of $1,645,291 and $3,724,069 for the three and nine months ended March 31, 2012, respectively, representing increases of $1,439,320 and $3,283,417, or 699% and 745%, compared to the corresponding fiscal 2011 periods. Net loss on the basis of accounting principles generally accepted in the United States (GAAP) was $3.47 million or $0.09 per share and $7.88 million or $0.23 per share in the three and nine months ended March 31, 2012, respectively, compared to $2.9 million and $6.7 million, or $0.12 and $0.33 per share in the three and nine months ended March 31, 2011, respectively.
CEO and President Eric C. Apfelbach, CFO William C. Hogoboom, and Executive Vice President Operations Charles W. Stankiewicz bought shares of ZBB stock.
PharMerica Corporation (NYSE:PMC): Executive Vice President and CFO Michael J. Culotta Bought 15,000 Shares
Executive Vice President and CFO of PharMerica Corporation (NYSE:PMC) Michael J. Culotta bought 15,000 shares on 06/14/2012 at an average price of $9.51. PharMerica Corporation is an institutional pharmacy services provider dedicated to providing quality customer service and innovative pharmacy solutions to institutional customers and patients in long-term care settings. PharMerica Corporation has a market cap of $300.3 million; its shares were traded at around $10.71 with a P/E ratio of 7.7 and P/S ratio of 0.1. PharMerica Corporation had an annual average earnings growth of 18.6% over the past 5 years.
PharMerica Corporation reported its financial results for the first quarter of 2012. Net income for the first quarter of 2012 was $5.6 million, or $0.19 per diluted common share, compared with $3.3 million, or $0.11 per diluted common share, for the same period in 2011. Revenues for the first quarter of 2012 were $498.9 million compared with $535.1 million for the first quarter of 2011, a decrease of 6.8%, primarily driven by weaker volumes and increased dispensing of high margin generics.
CEO Gregory S. Weishar, Executive Vice President and CFO Michael J. Culotta, and Executive Vice President William E. Monast bought shares of PMC stock.
For the complete list of stocks that bought by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.